Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension.

Background: The Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youth (MADDY) study evaluated the efficacy and safety of a multinutrient formula for children with ADHD and emotional dysregulation. The post-RCT open-label extension (OLE) compared the effect of treatment duration (8 wee...

Descripción completa

Detalles Bibliográficos
Publicado en:European Child & Adolescent Psychiatry Vol. 33; no. 5; pp. 1355 - 1368
Autores principales: Leung, Brenda M. Y., Srikanth, Priya, Robinette, Lisa, Bruton, Alisha M., Tost, Gabriella, Hatsu, Irene, Arnold, L. Eugene, Johnstone, Jeanette M.
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Springer Nature May2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178046251&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178046251
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10188827
        EJ3
      jtl: European Child & Adolescent Psychiatry
      issn: 10188827
      maglogo: N
    pubinfo:
      dt: May2024
      vid: 33
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        178046251
        164167603
        178046251
        178046251
        10.1007/s00787-023-02236-2
        178046251
      ppf: 1355
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Micronutrients for ADHD in youth (MADDY) study: comparison of results from RCT and open label extension.
      aug:
        au:
          Leung, Brenda M. Y.
          Srikanth, Priya
          Robinette, Lisa
          Bruton, Alisha M.
          Tost, Gabriella
          Hatsu, Irene
          Arnold, L. Eugene
          Johnstone, Jeanette M.
        affil: https://ror.org/044j76961 Faculty of Health Sciences, University of Lethbridge, 4401 University Drive, Lethbridge, AB, Canada
      sug:
        subj:
          Micronutrients Therapeutic Use
          Attention Deficit Hyperactivity Disorder Drug Therapy
          Treatment Duration
          Body Height
          Body Weight Evaluation
          Treatment Outcomes
          Human
          Funding Source
          Child
          Random Assignment
          Clinical Assessment Tools
          Scales
          Anthropometry
          Descriptive Statistics
          Randomized Controlled Trials
          Pretest-Posttest Control Group Design
          Comparative Studies
          Adolescence
          Child: 6-12 years
          Adolescent: 13-18 years
      ab: Background: The Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youth (MADDY) study evaluated the efficacy and safety of a multinutrient formula for children with ADHD and emotional dysregulation. The post-RCT open-label extension (OLE) compared the effect of treatment duration (8 weeks vs 16 weeks) on ADHD symptoms, height velocity, and adverse events (AEs). Methods: Children aged 6–12 years randomized to multinutrients vs. placebo for 8 weeks (RCT), received an 8–week OLE for a total of 16 weeks. Assessments included the Clinical Global Impression-Improvement (CGI-I), Child and Adolescent Symptom Inventory-5 (CASI-5), Pediatric Adverse Events Rating Scale (PAERS), and anthropometric measures (height and weight). Results: Of the 126 in the RCT, 103 (81%) continued in the OLE. For those initially assigned to placebo, CGI-I responders increased from 23% in the RCT to 64% in the OLE; those who took multinutrients for 16 weeks increased from 53% (RCT) to 66% responders (OLE). Both groups improved on the CASI-5 composite score and subscales from week 8 to week 16 (all p–values < 0.01). The group taking 16 weeks of multinutrients had marginally greater height growth (2.3 cm) than those with 8 weeks (1.8 cm) (p = 0.07). No difference in AEs between groups was found. Conclusion: The response rate to multinutrients by blinded clinician ratings at 8 weeks was maintained to 16 weeks; the response rate in the group initially assigned to placebo improved significantly with 8 weeks of multinutrients and almost caught up with 16 weeks. Longer time on multinutrients did not result in greater AEs, confirming an acceptable safety profile.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N